A detailed history of Collective Family Office LLC transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Collective Family Office LLC holds 79,363 shares of IBRX stock, worth $356,339. This represents 0.08% of its overall portfolio holdings.

Number of Shares
79,363
Previous 70,355 12.8%
Holding current value
$356,339
Previous $444,000 33.78%
% of portfolio
0.08%
Previous 0.13%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

BUY
$3.32 - $6.7 $29,906 - $60,353
9,008 Added 12.8%
79,363 $294,000
Q2 2024

Jul 05, 2024

BUY
$4.82 - $9.15 $339,111 - $643,748
70,355 New
70,355 $444,000

Others Institutions Holding IBRX

About ImmunityBio, Inc.


  • Ticker IBRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 400,304,000
  • Market Cap $1.8B
  • Description
  • ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...
More about IBRX
Track This Portfolio

Track Collective Family Office LLC Portfolio

Follow Collective Family Office LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Collective Family Office LLC, based on Form 13F filings with the SEC.

News

Stay updated on Collective Family Office LLC with notifications on news.